FeesSafety
Pluang+

LUKSO email recovery flaw exposed 300 profiles, stealing 1.4M LYX tokens

Protocol Fundamentals
19 Nov 2026, 03:18 WIB
Tokenpost
View Source
Bearish
LUKSO email recovery flaw exposed 300 profiles, stealing 1.4M LYX tokens

LUKSO revealed a security flaw in its email recovery process that exposed about 300 user profiles and resulted in the theft of approximately 1.4 million LYX tokens. The project is retiring the email recovery feature to prevent future incidents but affected users must still manually remove the attacker's key from their profiles. This two-step response addresses both the vulnerability and the cleanup of compromised accounts to secure user assets going forward.

LUKSO's recent security flaw and token theft provide context for cryptocurrency market conditions. For readers following major cryptocurrencies on Pluang as of Nov 19, 2026 08:21 WIB: out of 50 priced assets, only 8 rose while 40 fell. NEO traded at Rp28.715 with a 3.34% drop and 96% sell order activity, contrasting with AVAX at Rp127.696 which saw a 3.08% decline but 94% buy orders, and XLM at Rp2.491 down 2.96% with a more balanced 59% buy activity.

More News

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic is set to go public on November 19, raising tens of billions to boost its AI capabilities in bioscience, focusing on lab automation and robotics. Ginkgo Bioworks, a leader in automated biotech labs, collaborates with OpenAI but has no curre...

Market News
Bullish
58 minutes ago
BellRing shares jump 24% on strong sales and upbeat earnings forecast

BellRing shares jump 24% on strong sales and upbeat earnings forecast

BellRing Brands saw a 24% surge in its stock price after reporting a 7% increase in net sales to $692 million for fiscal 2026 Q4, driven by strong demand for its high-protein Premier Protein shakes and new product launches like Sparkling Protein Soda...

Company Fundamentals
Bullish
1 hour ago
Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Freedom Broker analyst Vitaly Kononov lowered Peabody Energy's price target from $30 to $22 per share, citing reduced production outlooks at its key Centurion coal mine and vulnerability in coal prices. Despite the significant cut, he maintained a bu...

Analyst Insights
Bearish
1 hour ago
Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
2 hours ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App